Catalyst Pharm Inc
(CPRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 64,069 | 23,275 | 71,410 | 36,566 | 67,330 |
| Depreciation Amortization | 18,865 | 9,430 | 32,881 | 23,738 | 15,170 |
| Income taxes - deferred | -3,359 | -1,746 | -17,818 | -18,701 | -4,758 |
| Accounts receivable | -3,658 | -6,979 | -43,075 | -37,610 | -32,357 |
| Accounts payable and accrued liabilities | -7,679 | -4,534 | 10,820 | 623 | 446 |
| Other Working Capital | -1 | -8,647 | -37,324 | -44,978 | -41,367 |
| Other Operating Activity | 27,823 | 21,126 | 126,706 | 128,314 | 38,360 |
| Operating Cash Flow | $96,060 | $31,925 | $143,600 | $87,952 | $42,824 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -209 | -199 | -231 | -138 | -74 |
| Purchase Of Investment | N/A | N/A | -13,465 | -13,465 | N/A |
| Other Investing Activity | 0 | 0 | -279,806 | -241,581 | -162,293 |
| Investing Cash Flow | $-209 | $-199 | $-293,502 | $-255,184 | $-162,367 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 144,553 | 142,522 | 2,792 | 2,099 | 1,887 |
| Other Financing Activity | -2,347 | -1,473 | -13,649 | -12,291 | -1,952 |
| Financing Cash Flow | $142,206 | $141,049 | $-10,857 | $-10,192 | $-65 |
| Beginning Cash Position | 137,636 | 137,636 | 298,395 | 298,395 | 298,395 |
| End Cash Position | 375,693 | 310,411 | 137,636 | 120,971 | 178,787 |
| Net Cash Flow | $238,057 | $172,775 | $-160,759 | $-177,424 | $-119,608 |
| Free Cash Flow | |||||
| Operating Cash Flow | 96,060 | 31,925 | 143,600 | 87,952 | 42,824 |
| Capital Expenditure | -209 | -199 | -231 | -138 | -74 |
| Free Cash Flow | 95,851 | 31,726 | 143,369 | 87,814 | 42,750 |